Mathys & Squire will be at Life Sciences Patent Network (LSPN) Europe in London, United Kingdom, on the 4th of November.
Partner Philippa Griffin will be attending LSPN Europe 2025 in London.
LSPN Europe 2025 is an annual event which aims to connect top patent experts and pioneers in innovative technology from around the globe.
The event offers the opportunity to gain professional advice and talk to like-minded individuals around the theme of protecting and leveraging innovation in the life sciences.
In an era of intensifying competition and an evolving regulatory framework, businesses in the fields of pharmaceuticals, biotechnology and chemistry must stay on top of their IP strategy to maintain a competitive edge.
Philippa Griffin is skilled in handling inventions relating to antibodies and immunology; synthetic biology, gene editing, cloning, and sequencing; nucleic acid-based therapies and delivery technologies; recombinant protein production and formulation; cardiac biology and diagnostics; tissue regeneration; and vaccines. She has expertise in prosecution, and opposition and appeal proceedings before the EPO, as well as constructing and coordinating successful IP strategies for a range of businesses.
Please reach out to our team if you are interested in arranging a meeting.
For more information on the event, visit the website here.
Contact our team
Philippa Griffin – Partner | [email protected]
